Tempus AI (TEM) closed at $79.43 on November 11 and slipped to $78.23 in the latest reading, after reporting third-quarter 2026 revenue of $411.5 million and raising full-year 2026 revenue guidance...
Tempus AI (TEM) is trading through a modest pullback after a strong quarterly update. Yahoo Finance said the company reported a strong Q3, with revenue up 23% and adjusted EPS of $0.07, while management raised 2026 revenue guidance to $1.60 billion to $1.605 billion. Tempus’ own Nov. 2 release said Q3 revenue reached $411.5 million, led by 32% unit growth in oncology and 33% revenue growth in Data & Applications. citeturn0search1turn0search3
That matters because the stock is no longer being driven only by top-line growth; it is also being judged on whether that growth can keep translating into scale, margin durability and execution. Yahoo Finance also flagged the main overhangs: reimbursement, valuation and profitability risk. citeturn0search1
Analyst coverage remains positive on balance, though the message is mixed. StockAnalysis said 20 analysts polled by S&P Global show a consensus “Buy” rating with an average price target of $89.56, versus a low of $70 and a high of $120. MarketBeat, however, cited a broader broker set with a consensus “Hold” rating across 22 brokerages and an average target of $79.37. citeturn0search0turn0search2
Needham lifted its target to $89 from $75 on Nov. 2, citing Tempus’ Q3 results, revenue and adjusted EBITDA beat, and data-business momentum. It also pointed to more than $550 million in bookings year to date, including wins and extensions from Merck and Bristol Myers Squibb.
Source link
